![Yutaro Kyono](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Yutaro Kyono
Società | Posizione | Inizio | Fine |
---|---|---|---|
Molcure, Inc.
![]() Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | Direttore Tecnico/Scientifico/R&S | 01/05/2013 | - |
Fondatore | 01/05/2013 | - |
Storia della carriera di Yutaro Kyono
Statistiche
Distribuzione geografica
Giappone | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Molcure, Inc.
![]() Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Yutaro Kyono
- Esperienza